[144] Agilent Technologies Inc. SEC Filing

Rhea-AI Filing Summary

Agilent Technologies Inc. (A) Form 144 shows a proposed sale of 21,644 common shares through Fidelity Brokerage Services with an aggregate market value of $2,706,365.76. The shares represent a small fraction of the 284,064,728 shares outstanding and the approximate sale date is 08/29/2025 on the NYSE. The shares to be sold were acquired upon option exercises dated 11/17/2020, 05/03/2022, and 11/22/2023, and payment is indicated as cash. The filer states there are no undisclosed material adverse facts and reports no securities sold in the past three months.

Positive

• Clear compliance with Rule 144 disclosure requirements: broker, share count, acquisition dates, and certification of no undisclosed material adverse information
• Full provenance of the securities provided: shares stem from option grants dated 11/17/2020, 05/03/2022, and 11/22/2023

Negative

• Insider liquidity event: proposed sale of 21,644 shares valued at $2,706,365.76, which may be interpreted by some investors as insider selling
• Concentration risk for filer: all securities to be sold were acquired via options and will be paid in cash on the same approximate sale date (08/29/2025)

Insights

Securities Analyst

TL;DR: Routine insider sale notice for 21,644 shares valued at about $2.7M; appears compliant with Rule 144.

The filing documents a proposed Rule 144 sale through a broker of 21,644 Agilent common shares, representing approximately 0.0076% of outstanding shares. The shares originate from option grants on three separate dates and will be paid in cash. No prior sales in the past three months are reported and the filer certifies no undisclosed material adverse information. From a market-impact standpoint, the size is small relative to the company's float, so direct price pressure is likely limited; the filing is primarily a compliance disclosure.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; the filing enhances transparency but signals insider liquidity.

The notice provides required details: broker, number of shares, acquisition dates, nature of acquisition (option grants), and intended sale date. The signer affirms absence of material nonpublic information. This is a standard governance disclosure enabling market transparency about insider liquidity events; it does not by itself indicate wrongdoing or governance issues based on the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21644	2706365.76	284064728	08/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/29/2025	Option Granted - 11/17/2020	Issuer			3435	08/29/2025	Cash
Common	08/29/2025	Option Granted - 05/03/2022	Issuer			4199	08/29/2025	Cash
Common	08/29/2025	Option Granted - 11/22/2023	Issuer			14010	08/29/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)